NEW YORK (360Dx) – Emosis recently announced it has received CE marking for its test to help in diagnosing heparin-induced thrombocytopenia.
The flow cytometry-based HIT Confirm test is a first-in-class functional test that provides results in 30 minutes by reading selected selected platelet biomarkers.. Functional tests, Emosis said, are technically demanding and need to be batched, requiring days or weeks for most hospitals to get results from a few specialized centers. In contrast, HIT Confirm "can timely contribute to the physician’s decision to substitute or not heparin with costly and more complex to manage alternative antithrombotic drugs."
"With this first kit and several others under development, Emosis wishes to use the power of flow cytometry and cell-based hemostasis to support a better informed clinical decision for physicians facing thrombosis or bleeding risks every day," Emosis CEO Frederic Allemand said in a statement.